SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Insite Vision Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gary Burton who wrote (136)1/5/1997 8:33:00 AM
From: Ron Oda   of 1060
 
You could be right about the price settling down right after the conference. Even without a deal though, there will be alot of great news for INSV to get out. Most of the people attending probably don't follow INSV. The new people finding out about INSV(or being reminded about them) could balance the people who are dissappointed that there is no signed deal. There may not be a deal announced at the conference, but the people attending the conference will probaly learn that the glaucoma gene deal is imminent. We take the glaucoma gene deal for granted, but it is still an exciting product. Considering that deal and the other products in the pipeline, INSV is undervalued. How long it takes for the information to get out or how much it affects the price, I don't know. My feeling right now is that there will be a price drop shortly after the conference but the price goes back up as INSV's story gets out. Anybody have any theories about how this could work out in the relative short term(couple months)?

RG
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext